Astellas Pharma Inc. Newsletter
-
Global Pharma Companies Rush to Invest in U.S., as Trump Administration Examines Tariff on Drug Imports
27 Apr 2025 11:09 GMT
… soon impose new tariffs on drug imports. Pharma companies are trying to … not affect pharmaceuticals, his administration has already begun investigating drug imports, looking … ,” said Naoki Okamura, president of Astellas Pharma Inc., at a press conference …
-
Astellas Pharma Inc. (ALPMF) Q4 2024 Earnings Call Transcript
26 Apr 2025 23:54 GMT
Astellas Pharma Inc. (OTCPK:ALPMF) Q4 2024 … Financial Results Announcement Meeting by Astellas Pharma Inc. out of your very … factors. They contain information on pharmaceuticals, including compounds under development, but …
-
Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance
25 Apr 2025 11:10 GMT
… by other companies.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (Nasdaq: IRWD) is a … Japan, Ironwood's partner, Astellas, markets linaclotide under the brand … product candidates, including abbreviated new drug application litigation; the risk …
-
Drug Targets Identified for Pancreatic Cancer
24 Apr 2025 21:56 GMT
… Oncology, RAPTTA Therapeutics, and Ascentage Pharmaceuticals. Chinnaiyan, Qiao, Lyssiotis, Cheng, Bao … years, Lyssiotis has consulted for Astellas Pharmaceuticals, Odyssey Therapeutics, Third Rock Ventures …
-
Strong sales for Cresemba® (isavuconazole) in Japan trigger second milestone payment from Asahi Kasei Pharma to Basilea
24 Apr 2025 05:15 GMT
… developing and commercializing innovative drugs to meet the needs of … or similar expressions concerning Basilea Pharmaceutica Ltd, Allschwil and its …
PMDA List of Approved Drugs April 2022 to March 2023 … : https://www.astellas.us/docs/cresemba …
-
Starke Verkäufe von Cresemba® (Isavuconazol) in Japan lösen zweite Umsatzmeilensteinzahlung von Asahi Kasei Pharma an Basilea aus
24 Apr 2025 05:15 GMT
… » oder ähnliche Ausdrücke betreffend Basilea Pharmaceutica AG, Allschwil und ihrer Geschäftsaktivitäten … -Dollar.
PMDA List of Approved Drugs April 2022 to March 2023 … -Verschreibungsinformationen: https://www.astellas.us/docs/cresemba …
-
Implications of Gene Therapy in Retina, With Christina Y. Weng, MD
26 Apr 2025 14:28 GMT
In a field marked by rapid innovation, gene therapy is emerging as one of the most promising advances in retinal disease treatment. At the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting, Christina Y. Weng, MD, MBA, a …
-
Headwinds and tailwinds on an even keel
26 Apr 2025 20:01 GMT
… year.
On April 17, Astellas Pharma, innovator of Mirabegron, won … which it may enter new drug application. It is also … from Gilead (North American major pharma company) — Seladelpar for … CVS’ formulary (US’ leading pharma benefits chain), assuring some …
-
Reshaping Retinal Care With Gene Therapy Programs, With Christina Y. Weng, MD
25 Apr 2025 23:03 GMT
… US Food and Drug Administration (FDA) recently approved Neurotech Pharmaceuticals’ Revakinagene taroretcel … disclosures with Alcon, AbbVie, Apellis, Astellas/Iveric Bio, Genentech, Regeneron …
-
Myasthenia Gravis Treatment Market anticipated to reach US$2.785 billion by 2030 at a CAGR of 7.14%
24 Apr 2025 13:51 GMT
… F.Hoffmann-La Roche Ltd, Astellas Pharma Inc., Bayer AG, Sanofi, among …
• F.Hoffmann-La Roche Ltd
• Astellas Pharma Inc.
• Bayer AG
• Sanofi
• Amneal … Pharmaceuticals LLC.
• Zydus Group
• Hikma Pharmaceuticals PLC
Reasons for …
About
© 1995-2025